Over-expression of miR-181a leads to increased viability of osteosarcoma cells and induced cell proliferation by augmenting BCL2, MMP9; and apoptosis was inhibited by down-regulation of p21 and TIMP3 expression [38]. Here, BCL2 is linked to osteosarcoma.